XADAGO  Exploring

XADAGO DOSING AND ADMINISTRATION1

  • XADAGO is now available in two dosages: 50 mg and 100 mg
  • The recommended starting dose is 50 mg once daily

XADAGO DOSAGE ADJUSTMENTS1


  • After 2 weeks, the 50 mg daily dosage may be increased to 100 mg/day on the basis of individual need and tolerability
  • If a dose is missed, the next dose should be taken at the same time the next day
  • XADAGO 100 mg/day should be tapered by decreasing the dose to 50 mg/day for one week before stopping
  • In patients with moderate hepatic impairment, a lower dosage of XADAGO(50 mg/day) should be used. XADAGO is contraindicated in patients with severe hepatic impairment (Child-Pugh C)
  • Dietary tyramine restriction is not required during treatment with recommended doses of XADAGO. However, patients should be advised to avoid foods containing a very high amount of tyramine because of the potential for severe increases in blood pressure, also referred to as hypertensive urgency, crisis, or emergency.
  • Can be used with SSRIs at the lowest effective SSRI dose

>87% of patients in clinical trials required no decrease in their levodopa dose2,3


See the XADAGO clinical trial results

Review the data

Find out if XADAGO is the right choice for your patients

Learn more
References
  1. XADAGO Full Prescribing Information. May 2017.
  2. Borgohain R, Szasz J, Stanzione P, et al. Randomized trial of Safinamide add-on to levodopa in Parkinson’s disease with motor fluctuations. Mov Disord. 2014;29(2):229-237.
  3. Schapira AHV, Fox SH, Hauser RA, et al. Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial. JAMA Neurol. 2016;E1-E9.